APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immune Health Product

Immune health products are health products that can improve immunity and promote metabolism.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Immune health products are health products that can improve immunity and promote metabolism.

Selected research

Market Outlook & Growth Opportunities

Global Immune Health Product Market Outlook and Growth Opportunities 2026

29 December 2025197 pages

Choose your research edition.

Industry ResearchImmune Health Product Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune Health Product Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Immune Health Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune Health Product Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune Health Product Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Immune health products are health products that can improve immunity and promote metabolism.

Global Immune Health Product key players include Amway, Suntory, GNC, INFINITUS, Herbalife Nutrition, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe and China, both have a share over 37 percent. In terms of product, Capsule/Pills is the largest segment, with a share over 81%. And in terms of End User, the largest End User is Adults, followed by Men, etc.

This report provides an overview of the global Immune Health Product market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Immune Health Product and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immune Health Product revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Immune Health Product market.

Immune Health Product Segment by Company

Amway

Suntory

GNC

INFINITUS

Herbalife Nutrition

USANA Health Sciences, Inc.

PERFECT

Nestlé SA

H&H Group

China New Era Group

By-health

Black Mores

Glanbia Plc

Nature’s

Real Nutriceutical

Immune Health Product Segment by Form

Capsule/Pills

Powder

Liquid

Immune Health Product Segment by End Users

Children/Teenagers

Men

Adults

The Elderly

Immune Health Product Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Immune Health Product status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Immune Health Product key companies, revenue, market share, and recent developments.

3. To split the Immune Health Product breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Immune Health Product market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Immune Health Product significant trends, drivers, influence factors in global and regions.

6. To analyze Immune Health Product competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Health Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune Health Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Health Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immune Health Product industry.

Chapter 3: Detailed analysis of Immune Health Product company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Immune Health Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Immune Health Product in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Immune Health Product Industry Trends Table 2. Immune Health Product Industry Drivers Table 3. Immune Health Product Industry Opportunities and Challenges Table 4. Immune Health Product Industry Restraints Table 5. Global Immune Health Product Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Immune Health Product Revenue Share by Company (2021-2026) Table 7. Global Immune Health Product Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Immune Health Product Key Company Manufacturing Base & Headquarters Table 9. Global Immune Health Product Company, Product Type & Application Table 10. Global Immune Health Product Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Immune Health Product by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Capsule/Pills Table 15. Significant Companies of Powder Table 16. Significant Companies of Liquid Table 17. Global Immune Health Product Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Immune Health Product Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Immune Health Product Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Immune Health Product Sales Value Share by Type (2021-2026) Table 21. Global Immune Health Product Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Children/Teenagers Table 23. Significant Companies of Men Table 24. Significant Companies of Adults Table 25. Significant Companies of The Elderly Table 26. Global Immune Health Product Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Immune Health Product Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Immune Health Product Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Immune Health Product Sales Value Share by Application (2021-2026) Table 30. Global Immune Health Product Sales Value Share by Application (2027-2032) Table 31. Global Immune Health Product Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Immune Health Product Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Immune Health Product Sales Value Share by Region (2021-2026) Table 34. Global Immune Health Product Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Immune Health Product Sales Value Share by Region (2027-2032) Table 36. Global Immune Health Product Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Immune Health Product Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Immune Health Product Sales Value Market Share by Country (2021-2026) Table 39. Global Immune Health Product Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Immune Health Product Sales Value Market Share by Country (2027-2032) Table 41. Amway Company Information Table 42. Amway Business Overview Table 43. Amway Immune Health Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Amway Immune Health Product Product Portfolio Table 45. Amway Recent Development Table 46. Suntory Company Information Table 47. Suntory Business Overview Table 48. Suntory Immune Health Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Suntory Immune Health Product Product Portfolio Table 50. Suntory Recent Development Table 51. GNC Company Information Table 52. GNC Business Overview Table 53. GNC Immune Health Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. GNC Immune Health Product Product Portfolio Table 55. GNC Recent Development Table 56. INFINITUS Company Information Table 57. INFINITUS Business Overview Table 58. INFINITUS Immune Health Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. INFINITUS Immune Health Product Product Portfolio Table 60. INFINITUS Recent Development Table 61. Herbalife Nutrition Company Information Table 62. Herbalife Nutrition Business Overview Table 63. Herbalife Nutrition Immune Health Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Herbalife Nutrition Immune Health Product Product Portfolio Table 65. Herbalife Nutrition Recent Development Table 66. USANA Health Sciences, Inc. Company Information Table 67. USANA Health Sciences, Inc. Business Overview Table 68. USANA Health Sciences, Inc. Immune Health Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. USANA Health Sciences, Inc. Immune Health Product Product Portfolio Table 70. USANA Health Sciences, Inc. Recent Development Table 71. PERFECT Company Information Table 72. PERFECT Business Overview Table 73. PERFECT Immune Health Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. PERFECT Immune Health Product Product Portfolio Table 75. PERFECT Recent Development Table 76. Nestlé SA Company Information Table 77. Nestlé SA Business Overview Table 78. Nestlé SA Immune Health Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Nestlé SA Immune Health Product Product Portfolio Table 80. Nestlé SA Recent Development Table 81. H&H Group Company Information Table 82. H&H Group Business Overview Table 83. H&H Group Immune Health Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. H&H Group Immune Health Product Product Portfolio Table 85. H&H Group Recent Development Table 86. China New Era Group Company Information Table 87. China New Era Group Business Overview Table 88. China New Era Group Immune Health Product Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. China New Era Group Immune Health Product Product Portfolio Table 90. China New Era Group Recent Development Table 91. By-health Company Information Table 92. By-health Business Overview Table 93. By-health Immune Health Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. By-health Immune Health Product Product Portfolio Table 95. By-health Recent Development Table 96. Black Mores Company Information Table 97. Black Mores Business Overview Table 98. Black Mores Immune Health Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Black Mores Immune Health Product Product Portfolio Table 100. Black Mores Recent Development Table 101. Glanbia Plc Company Information Table 102. Glanbia Plc Business Overview Table 103. Glanbia Plc Immune Health Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Glanbia Plc Immune Health Product Product Portfolio Table 105. Glanbia Plc Recent Development Table 106. Nature’s Company Information Table 107. Nature’s Business Overview Table 108. Nature’s Immune Health Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Nature’s Immune Health Product Product Portfolio Table 110. Nature’s Recent Development Table 111. Real Nutriceutical Company Information Table 112. Real Nutriceutical Business Overview Table 113. Real Nutriceutical Immune Health Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Real Nutriceutical Immune Health Product Product Portfolio Table 115. Real Nutriceutical Recent Development Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Immune Health Product Product Image Figure 2. Global Immune Health Product Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immune Health Product Market Size (2021-2032) & (US$ Million) Figure 4. Global Immune Health Product Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Capsule/Pills Image Figure 8. Powder Image Figure 9. Liquid Image Figure 10. Global Immune Health Product Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Immune Health Product Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Immune Health Product Sales Value Share by Type (2021-2032) Figure 13. Children/Teenagers Image Figure 14. Men Image Figure 15. Adults Image Figure 16. The Elderly Image Figure 17. Global Immune Health Product Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Immune Health Product Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Immune Health Product Sales Value Share by Application (2021-2032) Figure 20. Global Immune Health Product Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Immune Health Product Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Immune Health Product Sales Value (2021-2032) & (US$ Million) Figure 23. North America Immune Health Product Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Immune Health Product Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Immune Health Product Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Immune Health Product Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Immune Health Product Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Immune Health Product Sales Value (2021-2032) & (US$ Million) Figure 29. South America Immune Health Product Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Immune Health Product Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Immune Health Product Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Immune Health Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Immune Health Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Immune Health Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule/Pills
  • Powder
  • Liquid
Applications
  • Children/Teenagers
  • Men
  • Adults
  • The Elderly
Companies covered
  • Amway
  • Suntory
  • GNC
  • INFINITUS
  • Herbalife Nutrition
  • USANA Health Sciences, Inc.
  • PERFECT
  • Nestlé SA
  • H&H Group
  • China New Era Group
  • By-health
  • Black Mores
  • Glanbia Plc
  • Nature’s
  • Real Nutriceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Immune Health Product Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Immune Health Product Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Immune Health Product Market Dynamics
  1. 2.1 Immune Health Product Industry Trends
  2. 2.2 Immune Health Product Industry Drivers
  3. 2.3 Immune Health Product Industry Opportunities and Challenges
  4. 2.4 Immune Health Product Industry Restraints
3 Immune Health Product Market by Company
  1. 3.1 Global Immune Health Product Company Revenue Ranking in 2025
  2. 3.2 Global Immune Health Product Revenue by Company (2021-2026)
  3. 3.3 Global Immune Health Product Company Ranking (2024-2026)
  4. 3.4 Global Immune Health Product Company Manufacturing Base and Headquarters
  5. 3.5 Global Immune Health Product Company Product Type and Application
  6. 3.6 Global Immune Health Product Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Immune Health Product Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Immune Health Product Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Immune Health Product Market by Type
  1. 4.1 Immune Health Product Type Introduction
  2. 4.1.1 Capsule/Pills
  3. 4.1.2 Powder
  4. 4.1.3 Liquid
  5. 4.2 Global Immune Health Product Sales Value by Type
  6. 4.2.1 Global Immune Health Product Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Immune Health Product Sales Value by Type (2021-2032)
  8. 4.2.3 Global Immune Health Product Sales Value Share by Type (2021-2032)
5 Immune Health Product Market by Application
  1. 5.1 Immune Health Product Application Introduction
  2. 5.1.1 Children/Teenagers
  3. 5.1.2 Men
  4. 5.1.3 Adults
  5. 5.1.4 The Elderly
  6. 5.2 Global Immune Health Product Sales Value by Application
  7. 5.2.1 Global Immune Health Product Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Immune Health Product Sales Value by Application (2021-2032)
  9. 5.2.3 Global Immune Health Product Sales Value Share by Application (2021-2032)
6 Immune Health Product Regional Value Analysis
  1. 6.1 Global Immune Health Product Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immune Health Product Sales Value by Region (2021-2032)
  3. 6.2.1 Global Immune Health Product Sales Value by Region: 2021-2026
  4. 6.2.2 Global Immune Health Product Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Immune Health Product Sales Value (2021-2032)
  7. 6.3.2 North America Immune Health Product Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Immune Health Product Sales Value (2021-2032)
  10. 6.4.2 Europe Immune Health Product Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Immune Health Product Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Immune Health Product Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Immune Health Product Sales Value (2021-2032)
  16. 6.6.2 South America Immune Health Product Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Immune Health Product Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Immune Health Product Sales Value Share by Country, 2025 VS 2032
7 Immune Health Product Country-level Value Analysis
  1. 7.1 Global Immune Health Product Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Immune Health Product Sales Value by Country (2021-2032)
  3. 7.2.1 Global Immune Health Product Sales Value by Country (2021-2026)
  4. 7.2.2 Global Immune Health Product Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Immune Health Product Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Immune Health Product Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Immune Health Product Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Immune Health Product Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Immune Health Product Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Immune Health Product Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Immune Health Product Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Immune Health Product Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Immune Health Product Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Immune Health Product Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Immune Health Product Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Immune Health Product Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Immune Health Product Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Immune Health Product Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Immune Health Product Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Immune Health Product Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Immune Health Product Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Immune Health Product Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Immune Health Product Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Immune Health Product Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Immune Health Product Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Immune Health Product Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Immune Health Product Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Immune Health Product Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Immune Health Product Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Immune Health Product Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Immune Health Product Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Immune Health Product Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Immune Health Product Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Immune Health Product Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Immune Health Product Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Immune Health Product Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Immune Health Product Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Immune Health Product Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Immune Health Product Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Immune Health Product Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Immune Health Product Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Immune Health Product Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Immune Health Product Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Immune Health Product Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Immune Health Product Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Immune Health Product Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Immune Health Product Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Immune Health Product Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Immune Health Product Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Immune Health Product Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Immune Health Product Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Immune Health Product Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Immune Health Product Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Immune Health Product Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Immune Health Product Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Immune Health Product Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Immune Health Product Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Immune Health Product Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Immune Health Product Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Immune Health Product Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Immune Health Product Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Immune Health Product Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Immune Health Product Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Immune Health Product Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Immune Health Product Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Immune Health Product Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Immune Health Product Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Immune Health Product Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Immune Health Product Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Immune Health Product Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Immune Health Product Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Immune Health Product Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Immune Health Product Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Immune Health Product Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Immune Health Product Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Immune Health Product Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Immune Health Product Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Immune Health Product Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Immune Health Product Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Immune Health Product Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Immune Health Product Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Immune Health Product Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Immune Health Product Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Immune Health Product Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Immune Health Product Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Immune Health Product Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Immune Health Product Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Immune Health Product Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Amway
  2. 8.1.1 Amway Company Information
  3. 8.1.2 Amway Business Overview
  4. 8.1.3 Amway Immune Health Product Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Amway Immune Health Product Product Portfolio
  6. 8.1.5 Amway Recent Developments
  7. 8.2 Suntory
  8. 8.2.1 Suntory Company Information
  9. 8.2.2 Suntory Business Overview
  10. 8.2.3 Suntory Immune Health Product Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Suntory Immune Health Product Product Portfolio
  12. 8.2.5 Suntory Recent Developments
  13. 8.3 GNC
  14. 8.3.1 GNC Company Information
  15. 8.3.2 GNC Business Overview
  16. 8.3.3 GNC Immune Health Product Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GNC Immune Health Product Product Portfolio
  18. 8.3.5 GNC Recent Developments
  19. 8.4 INFINITUS
  20. 8.4.1 INFINITUS Company Information
  21. 8.4.2 INFINITUS Business Overview
  22. 8.4.3 INFINITUS Immune Health Product Revenue and Gross Margin (2021-2026)
  23. 8.4.4 INFINITUS Immune Health Product Product Portfolio
  24. 8.4.5 INFINITUS Recent Developments
  25. 8.5 Herbalife Nutrition
  26. 8.5.1 Herbalife Nutrition Company Information
  27. 8.5.2 Herbalife Nutrition Business Overview
  28. 8.5.3 Herbalife Nutrition Immune Health Product Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Herbalife Nutrition Immune Health Product Product Portfolio
  30. 8.5.5 Herbalife Nutrition Recent Developments
  31. 8.6 USANA Health Sciences, Inc.
  32. 8.6.1 USANA Health Sciences, Inc. Company Information
  33. 8.6.2 USANA Health Sciences, Inc. Business Overview
  34. 8.6.3 USANA Health Sciences, Inc. Immune Health Product Revenue and Gross Margin (2021-2026)
  35. 8.6.4 USANA Health Sciences, Inc. Immune Health Product Product Portfolio
  36. 8.6.5 USANA Health Sciences, Inc. Recent Developments
  37. 8.7 PERFECT
  38. 8.7.1 PERFECT Company Information
  39. 8.7.2 PERFECT Business Overview
  40. 8.7.3 PERFECT Immune Health Product Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PERFECT Immune Health Product Product Portfolio
  42. 8.7.5 PERFECT Recent Developments
  43. 8.8 Nestlé SA
  44. 8.8.1 Nestlé SA Company Information
  45. 8.8.2 Nestlé SA Business Overview
  46. 8.8.3 Nestlé SA Immune Health Product Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nestlé SA Immune Health Product Product Portfolio
  48. 8.8.5 Nestlé SA Recent Developments
  49. 8.9 H&H Group
  50. 8.9.1 H&H Group Company Information
  51. 8.9.2 H&H Group Business Overview
  52. 8.9.3 H&H Group Immune Health Product Revenue and Gross Margin (2021-2026)
  53. 8.9.4 H&H Group Immune Health Product Product Portfolio
  54. 8.9.5 H&H Group Recent Developments
  55. 8.10 China New Era Group
  56. 8.10.1 China New Era Group Company Information
  57. 8.10.2 China New Era Group Business Overview
  58. 8.10.3 China New Era Group Immune Health Product Revenue and Gross Margin (2021-2026)
  59. 8.10.4 China New Era Group Immune Health Product Product Portfolio
  60. 8.10.5 China New Era Group Recent Developments
  61. 8.11 By-health
  62. 8.11.1 By-health Company Information
  63. 8.11.2 By-health Business Overview
  64. 8.11.3 By-health Immune Health Product Revenue and Gross Margin (2021-2026)
  65. 8.11.4 By-health Immune Health Product Product Portfolio
  66. 8.11.5 By-health Recent Developments
  67. 8.12 Black Mores
  68. 8.12.1 Black Mores Company Information
  69. 8.12.2 Black Mores Business Overview
  70. 8.12.3 Black Mores Immune Health Product Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Black Mores Immune Health Product Product Portfolio
  72. 8.12.5 Black Mores Recent Developments
  73. 8.13 Glanbia Plc
  74. 8.13.1 Glanbia Plc Company Information
  75. 8.13.2 Glanbia Plc Business Overview
  76. 8.13.3 Glanbia Plc Immune Health Product Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Glanbia Plc Immune Health Product Product Portfolio
  78. 8.13.5 Glanbia Plc Recent Developments
  79. 8.14 Nature’s
  80. 8.14.1 Nature’s Company Information
  81. 8.14.2 Nature’s Business Overview
  82. 8.14.3 Nature’s Immune Health Product Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Nature’s Immune Health Product Product Portfolio
  84. 8.14.5 Nature’s Recent Developments
  85. 8.15 Real Nutriceutical
  86. 8.15.1 Real Nutriceutical Company Information
  87. 8.15.2 Real Nutriceutical Business Overview
  88. 8.15.3 Real Nutriceutical Immune Health Product Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Real Nutriceutical Immune Health Product Product Portfolio
  90. 8.15.5 Real Nutriceutical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst